Abcam Yönetim

Yönetim kriter kontrolleri 4/4

Abcam CEO'su Alan Hirzel, Sep2014 tarihinde atandı, in görev süresi 9.25 yıldır. in toplam yıllık tazminatı £ 3.02M olup, şirket hissesi ve opsiyonları dahil olmak üzere 20.9% maaş ve 79.1% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.13% ine doğrudan sahiptir ve bu hisseler $ 7.12M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.8 yıl ve 3.8 yıldır.

Anahtar bilgiler

Alan Hirzel

İcra Kurulu Başkanı

UK£3.0m

Toplam tazminat

CEO maaş yüzdesi	20.9%
CEO görev süresi	9.3yrs
CEO sahipliği	0.1%
Yönetim ortalama görev süresi	3.8yrs
Yönetim Kurulu ortalama görev süresi	3.8yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Alan Hirzel'un ücretlendirmesi Abcam'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2023	n/a	n/a	UK£3m
Mar 31 2023	n/a	n/a	-UK£3m
Dec 31 2022	UK£3m	UK£630k	-UK£8m
Sep 30 2022	n/a	n/a	-UK£600k
Jun 30 2022	n/a	n/a	UK£7m
Mar 31 2022	n/a	n/a	UK£6m
Dec 31 2021	UK£4m	UK£945k	UK£4m
Jun 30 2021	n/a	n/a	UK£16m
Mar 31 2021	n/a	n/a	UK£7m
Dec 31 2020	n/a	n/a	UK£26m
Sep 30 2020	n/a	n/a	UK£5m
Jun 30 2020	UK£2m	UK£615k	UK£13m
Mar 31 2020	n/a	n/a	UK£27m
Dec 31 2019	n/a	n/a	UK£43m
Sep 30 2019	n/a	n/a	UK£44m
Jun 30 2019	UK£2m	UK£600k	UK£44m
Mar 31 2019	n/a	n/a	UK£51m
Dec 31 2018	n/a	n/a	UK£58m
Sep 30 2018	n/a	n/a	UK£60m
Jun 30 2018	UK£2m	UK£492k	UK£62m
Mar 31 2018	n/a	n/a	UK£59m
Dec 31 2017	n/a	n/a	UK£55m
Sep 30 2017	n/a	n/a	UK£49m
Jun 30 2017	UK£1m	UK£480k	UK£42m

Tazminat ve Piyasa: Alan 'nin toplam tazminatı ($USD 3.79M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 7.92M ).

Tazminat ve Kazançlar: Alan 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Alan Hirzel (55 yo)

9.3yrs

Görev süresi

UK£3,017,000

Tazminat

Mr. Alan Thomas Hirzel, BS, MS, MBA, has been the Chief Executive Officer of Abcam Plc since September 8, 2014 and its Executive Director since January 30, 2014. Mr. Hirzel served as the Chief Marketing Of...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Alan Hirzel	CEO & Executive Director	9.3yrs	UK£3.02m	0.13% $ 7.1m
Michael Baldock	CFO & Director	3.8yrs	UK£1.28m	0.0084% $ 461.5k
Marc Leigh Perkins	General Counsel & Company Secretary	4.8yrs	Veri yok	Veri yok
Emma Sceats	Senior Vice President of Sales & Marketing	less than a year	Veri yok	Veri yok
Nick Skinner	Senior Vice President of Human Resources	7.9yrs	Veri yok	Veri yok
Alejandra Solache	Senior Vice President of Research & Development	less than a year	Veri yok	Veri yok
John Baker	Senior Vice President of Supply Chain & Manufacturing	no data	Veri yok	Veri yok
Juan Sacristan	Senior Vice President of Data & Digital	3.8yrs	Veri yok	Veri yok

3.8yrs

Ortalama Görev Süresi

Deneyimli Yönetim: ABCM 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.8 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Alan Hirzel	CEO & Executive Director	9.9yrs	UK£3.02m	0.13% $ 7.1m
Michael Baldock	CFO & Director	3.8yrs	UK£1.28m	0.0084% $ 461.5k
Sally Crawford	Independent Non-Executive Director	2.3yrs	UK£90.00k	0.00026% $ 14.4k
Giles F. Kerr	Senior Independent Director	5yrs	UK£90.00k	0.0014% $ 76.7k
Peter Allen	Independent Non-Executive Chairman of the Board	5.5yrs	UK£285.00k	0.010% $ 557.5k
Mara Aspinall	Independent Non-Executive Director	8.3yrs	UK£79.00k	0.0076% $ 421.7k
Mark Capone	Independent Non-Executive Director	2.9yrs	UK£77.00k	0.00069% $ 38.1k
Chien Ling Lee	Independent Non-Executive Director	2.9yrs	UK£82.00k	0.00044% $ 24.3k
Luba Greenwood	Independent Non-Executive Director	1.3yrs	UK£23.00k	Veri yok

3.8yrs

Ortalama Görev Süresi

61yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: ABCM 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.8 yıldır).

Abcam Yönetim

Yönetim kriter kontrolleri 4/4

Anahtar bilgiler

Son yönetim güncellemeleri

Abcam plc Appoints Luba Greenwood as Non-Executive Director

Abcam plc, Annual General Meeting, May 18, 2022

Abcam plc Appoints Non-Executive Directors

Abcam plc, Annual General Meeting, Dec 04, 2020

Recent updates

Abcam Files Form 15

Abcam plc(NasdaqGS:ABCM) dropped from NASDAQ Composite Index

Jonathan Milner Issues Statement Responding to the Glass Lewis Report

Jonathan Milner Continues Opposition to Danaher Corporation Acquisition

Jonathan Milner Releases Presentation to Abcam plc Shareholders

Jonathan Milner issues Open Letter to shareholders of Abcam plc

Jonathan Milner issues Open Letter to Shareholders of Abcam plc

Jonathan Milner Opposes Danaher's Acquisition of Abcam

Abcam plc Suspends Financial Guidance for the Fiscal 2023 and Fiscal 2024

Abcam plc Suspends Financial Guidance for the Fiscal 2023 and Fiscal 2024

Danaher Corporation (NYSE:DHR) entered into definitive agreement to acquire Abcam plc (NasdaqGS:ABCM) for $5.7 billion.

Jonathan Milner Sends an Open Letter to Abcam plc

Abcam plc Provides Revenue Guidance for the First Half Ending June 30, 2023

Jonathan Milner Announces Suspension of Proxy Solicitation

Abcam plc Provides Revenue Guidance for Fy2023 and Fy2024

Jonathan Milner Issues an Open Letter to shareholders of Abcam plc

Jonathan Milner Sends a Letter to Abcam plc

Jonathan Milner issues Open Letter to shareholders of Abcam plc

Jonathan Milner Calls Extraordinary General Meeting to Replace Directors at Abcam

Abcam plc Reiterates Earnings Guidance for the Years 2023 and 2024

Abcam plc to Report Fiscal Year 2022 Results on Mar 20, 2023

Abcam Provides Update on AIM Delisting

Abcam plc Announces Proposed Cancellation of AIM Shares

Abcam: A Good Growth Stock In The Healthcare Market

Abcam plc Provides Revenue Guidance for the Full Year Ending December 31, 2022

Abcam plc Appoints Luba Greenwood as Non-Executive Director

Abcam ADS Non-GAAP EPS of 14.00p, revenue of £185.2M

Abcam Board Decides to Pursue A Proposal to Cancel the Admission of the Shares to Trading on Aim

Abcam plc to Report First Half, 2022 Results on Sep 12, 2022

Abcam plc, Annual General Meeting, May 18, 2022

Abcam plc to Report 18 Months Period Ending Dec 31, 2021 Results on Mar 14, 2022

Abcam plc Provides Group Revenue Guidance for the Twelve Months Ended 31 December 2021

Abcam plc Provides Revenue Guidance for the Six-Months to 31 December 2021 and Year Ending December 31, 2024

Abcam plc (AIM:ABC) entered into a definitive agreement to acquire BioVision, Inc. from Boai NKY Medical Holdings Ltd. (SZSE:300109) for approximately $340 million.

Abcam: A Promising Business Model In The Drug Industry

Abingdon Health Signs Collaboration and Co-Marketing Agreement with Abcam

Abcam plc Appoints Non-Executive Directors

Abcam rallies on 1H trading update

Abcam plc to Report Q2, 2021 Results on Mar 08, 2021

Abcam plc, Annual General Meeting, Dec 04, 2020

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş